Jinhe Biotechnology Subsidiary Secures Patent for Combined Swine Fever and Circovirus Subunit Vaccine

Product / Tech
โดย 中国证券报·Read original
Summary · why it matters

Jinhe Biotechnology subsidiary Jinhe Youben Biological Products has recently obtained an invention patent in the field of veterinary biological products. The patent, titled "A fusion protein comprising classical swine fever virus E2 protein and porcine circovirus type 2 Cap protein and a bivalent subunit vaccine," involves the fusion expression of E2, Fc, and Cap proteins, enabling the simultaneous production of subunit vaccines for both viruses in a single expression process with a simple purification procedure. The company stated that obtaining this patent will help protect and leverage its independent intellectual property advantages, maintain its technological leadership, and enhance its core competitiveness.

Impact on stocks 1

Others · 1 stocks
Jinhe Biotechnology Co Ltd
002688
▲ PositiveTechnologyrelevance

Subsidiary secures patent for combined swine fever and circovirus subunit vaccine, enhancing IP and competitiveness.

Off-coverage companies 1

金河佑本生物制品有限公司Private▲ Positive
Technologyrelevance

Subsidiary secures patent for combined swine fever and circovirus subunit vaccine, enhancing IP and competitiveness.